Eagle Pharmacy, Inc.

FDA inspection history across 2 sites, 2016 to 2025

4
Form 483s
2
Warning letters

Every document, by year

  • Form 483
  • Warning letter

2016: one warning letter; 2018: one Form 483; 2020: one Form 483; 2021: one Form 483; 2022: one warning letter; 2025: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2016–22Three Form 483s and two warning letters, at Hoover, Alabama and Alabama.
  2. 2020The longest 483 on file: 10 observations over 7 pages at Hoover, Alabama.
  3. 2025One Form 483, at Hoover, Alabama.

Cited most

Across all Eagle Pharmacy observations on file

The complete Eagle Pharmacy file.

All 6 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$505$594

15% off buying them one by one

Sites

Documents

6 on file, newest first
DateDocumentPrice
2025-02-27483 Form 483$99
2022-05-17Warning letter Warning letter$99
2021-08-12483 Form 483$99
2020-08-03483 Form 483$99
2018-05-18483 Form 483$99
2016-10-13Warning letter Warning letter$99

FEI number 3011688532 · most recent document Feb 27, 2025

About Eagle Pharmacy, Inc.

How many FDA Form 483s has Eagle Pharmacy, Inc. received?

FDA Intel has 4 Form 483s on file for Eagle Pharmacy, Inc.; the most recent is dated Feb 27, 2025.

When was Eagle Pharmacy, Inc. last inspected by FDA?

The most recent FDA inspection document on file for Eagle Pharmacy, Inc. is a Form 483 dated Feb 27, 2025, for the site in Hoover, Alabama.

What did FDA cite at Eagle Pharmacy, Inc.?

The regulations cited most in the observations on file for Eagle Pharmacy, Inc. are 21 CFR 211.42 (Design and construction features), 6 times; 21 CFR 211.113 (Control of microbiological contamination), 4 times; 21 CFR 211.160 (General requirements), 4 times.

Has Eagle Pharmacy, Inc. received an FDA warning letter?

Yes. FDA Intel has 2 FDA warning letters on file for Eagle Pharmacy, Inc.; the most recent is dated May 17, 2022.

Eagle Pharmacy, Inc. FDA Inspection History & 483s · FDA Intel